Synthesis, characterization, and anti-inflammatory evaluation of 1,2,4-oxadiazoles combined with thiosemicarbazide and 1,3,4-oxadiazole moieties

Journal of Heterocyclic Chemistry

Volumn 46, Issue 4, 2009, Pages 722-727

  Dos Santos Filho, José M ^a   De Lima, José G ^a   Leite, Lúcia F C C ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b CATHOLIC UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 1,3,4 OXADIAZOLE DERIVATIVE; 5 (3 PHENYL 1,2,4 OXADIAZOL 5 YL) 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 BROMOPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 CHLOROPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 FLUOROPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYAMINO) 1,3,4 OXADIAZOLEL; 5 [3 (4 HYDROXYPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 METHOXYPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 NITROPHENYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; 5 [3 (4 TOLYL) 1,2,4 OXADIAZOL 5 YL] 2 (N PHENYLAMINO) 1,3,4 OXADIAZOLE; CARRAGEENAN; DICLOFENAC; N1 (3 PHENYL 1,2,4 OXADIAZOL 5 YLCARBONYL) N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 BROMOPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 CHLOROPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 FLUOROPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 HYDROXYPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 METHOXYPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 NITROPHENYL) 1,2,4 OXADIAZOL 5 YLCARBONYL] N4 PHENYLTHIOSEMICARBAZIDE; N1 [3 (4 TOLYL) 1,2,4 OXADIAZOL 5 YLCAYBONYL] N4 PHENYLTHIOSEMICARBAZIDE; NONSTEROID ANTIINFLAMMATORY AGENT; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CYCLIZATION; DRUG SYNTHESIS; EDEMA; NONHUMAN; POLYMERIZATION; RAT; RING CLOSING METATHESIS; RING OPENING;

EID: 67749108372     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.133     Document Type: Article

References (30)

1. Talley, J. J.; Brown, D. L.; Carter, J. S.; Graneto, M. J.; Koboldt, C. M.; Masferrer, J. L.; Perkins, W. E.; Rogers, R. S.; Shaffer, A. F.; Zhang, Y. Y.; Zweifel, B. S.; Seibert, K. J Med Chem 2000, 43, 775.
2. Palomer, A.; Cabr, F.; Pascual, J.; Campos, J.; Trujillo, M. A.; Entrena, A.; Gallo, M. A.; Garcia, L.; Maulen, D.; Espinosa, A. J Med Chem 2002, 45, 1402.
3. Sorbera, L. A.; Leeson, P. A.; Castaner, J.; Castaner, R. M. Drugs Future 2001, 26, 133.
4. Allison, M. C.; Howatson, A. G.; Torrance, C. J.; Lee, F. D.; Russell, R. I. G. N Engl J Med 1992, 327, 749.
5. Kimmey, M.B. J Rheumatol 1992, 19, 68.
6. Randall, L.O. Physiological Pharmacology; Academic Press: New York, 1963; pp 313-320.
7. Shen, T. Y. J Med Chem 1981, 24, 1.
8. Smith, C. J.; Zhang, Y.; Koboldt, C. M.; Muhammad, J.; Zweifel, B. S.; Shaffer, A.; Talley, J. J.; Masferrer, J. L.; Serbet, K.; Isakson, P. C. Proc Natl Acad Sci USA 1998, 95, 13313.
9. Vane, J. R. Nature 1971, 231, 232.
10. Schoen, R. T.; Vender, R. J. Am J Med 1989, 86, 449.
11. Hawkey, C.; Laine, L.; Simon, T.; Beaulieu, A.; Maldonado-Coco, J.; Acevedo, E.; Shahane, A.; Quan, H.; Bolognese, J.; Mortensen, E. Arthritis Rheum 2000, 43, 370.
12. Nicolaides, D. N.; Fylaktakidou, K. C.; Litinas, K. E.; Hadjipavlou-Litina, D. Eur J Med Chem 1998, 33, 715.
13. Unangst, P. C.; Shrum, G. P.; Connor, D. T.; Dyer, R. D.; Schrier, D. J. J Med Chem 1992, 35, 3691.
14. Bezerra, N. M. M.; de Oliveira, S. P.; Srivastava, R. M.; da Silva, J. R. Farmaco 2005, 60, 955.
15. Ramalingam, T.; Sattur, P. B. Eur J Med Chem 1990, 25, 541.
16. Mullican, M. D.; Wilson, M. W.; Conner, D. T.; Kostlan, C. R.; Schrier, D. J.; Dyer, R. D. J Med Chem 1993, 36, 1090.
17. Omar, F. A.; Mahfouz, N. M.; Rahman, M. A. Eur J Med Chem 1996, 31, 819.
18. Amir, M.; Oberoi, A.; Alam, S. Indian J Chem 1999, 38B, 237.
19. Tozkoparan, B.; Gokhan, N.; Aktay, G.; Yesilada, E.; Ertan, M. Eur J Med Chem 2000, 35, 743.
20. Kishore, V.; Kumar, S.; Narain, N. K.; Parma, S. S.; Stenberg, V. I. Pharmacology 1976, 14, 390.
21. Mohan, R. R.; Agarwal, R.; Misra, V. S. Indian J Chem 1985, 24B, 78.
22. Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N. T.; Altinok, G. Pharmaco 2002, 57, 101.
23. Santos-Filho, J. M.; de Lima, J. G.; Leite, L. F. C. C.; Ximenes, E. A.; da Silva, J. B. P.; Lima, P. C.; Pitta, I. R. Heterocycl. Commun. 2005, 11, 29.
24. (a) Hiremath, S. P.; Biradir, J. S.; Kudari, S. M. J. Ind. Chem. Soc. 1984, 61, 74;
25. (b) Amir, M.; Khan, M. S. Y.; Zaman, M. S. Ind. J. Chem. Sect. B 2004, 43B, 2189;
26. (c) Amir, M.; Kumar, S. Ind. J. Heterocycl. Chem. 2004, 14, 51.
27. (a) Ahmed, M. M.; Aboulwafa, O. M.; Kader, O. Monatsch Chem 1989, 120, 571;
28. (b) Aboulwafa, O. M.; Omar, A.; Mohsen, M. E. Sulfur Lett 1992, 14, 181;
29. (c) Coppo, F. T.; Evans, K. A.; Graybill, T. L.; Burton, G. Tetrahedron Lett 2004, 45, 3257.
30. Winter, C. A.; Risely, E. A.; Nuss, G. W. Proc Soc Exp Biol Med 1962, 111, 544.